Market Cap 82.02M
Revenue (ttm) 340,000.00
Net Income (ttm) -39.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11,588.24%
Debt to Equity Ratio -0.54
Volume 66,400
Avg Vol 124,728
Day's Range N/A - N/A
Shares Out 10.07M
Stochastic %K 39%
Beta 0.62
Analysts Strong Sell
Price Target $30.43

Company Profile

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; comp...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 801 676 9695
Website: clene.com
Address:
6550 South Millrock Drive, Suite G50, Salt Lake City, United States
neuroinvestor3
neuroinvestor3 Oct. 25 at 11:46 AM
$CLNN from chatGPT - “I assess the probability of accelerated approval next year for CNM-Au8 in ALS at a moderate but not high level — perhaps in the 30-50% range, contingent on many moving parts.“
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Oct. 25 at 5:48 AM
$CLNN December? I'm ba patient man, but let's talk about November, anyways. Now, then, according to GOOGLE: "By acting as a surrogate endpoint for clinical benefit, NfL data can speed up the drug development process. For rare diseases (like ALS) with limited treatment options, regulatory agencies like the FDA may approve a drug based on strong NfL data alone, with confirmatory trials to follow."
0 · Reply
fibonacci1170
fibonacci1170 Oct. 24 at 8:58 PM
$CLNN 91% reduction in "time to death" after 12 months of therapy. Even the sleazy FDA can't deny accelerated approval, surely. If they do deny, ALS patients should sue the FDA in court and demand an FBI probe. Unfortunately, these government agencies are only good at probing some small-fish casinos that nobody cares about instead of exposing the FDA-pharma mafia that is slaughtering millions of patients by denying them treatment.
0 · Reply
Mulhollandr
Mulhollandr Oct. 24 at 5:32 PM
$CLNN just my opinion but I think someone is grabbigg by shares quietly trying not to spike the price. Wonder when they will be done loading. 🤔
1 · Reply
ransoms2121212
ransoms2121212 Oct. 24 at 3:43 PM
$CLNN volume off to a strong start
1 · Reply
Mulhollandr
Mulhollandr Oct. 23 at 9:47 PM
$CLNN FDA minutes or EAP data…which do we get first? If they are still thinking nda submission could happen this year…data is coming soon? I think shutdown will slow down minutes from type C.
3 · Reply
Scoops1212
Scoops1212 Oct. 23 at 8:12 PM
0 · Reply
Chris150
Chris150 Oct. 23 at 7:31 PM
$CLNN https://www.youtube.com/watch?v=DIo6uZV8sog
0 · Reply
Acx21
Acx21 Oct. 23 at 7:25 PM
$CLNN I was listening to the conference and to make it short: The NfL data is not analysed yet or not available to CLNN by now. Still, Rob seemed to be very confident about a succesful NDA in december if the NfL data is concordant to previous results. The next FDA meeting is scheduled for december and so is the planned timeline for the NDA filling
0 · Reply
LXP
LXP Oct. 23 at 7:24 PM
$CLNN whelp, thoughts? Seems like a little more waiting. Nfl data likely in November. Fda meeting in December. NDA if all goes well, by EOY
0 · Reply
Latest News on CLNN
Clene to Present at the Emerging Growth Conference

Oct 20, 2025, 8:30 AM EDT - 5 days ago

Clene to Present at the Emerging Growth Conference


Clene to Present at the Canaccord 45th Annual Growth Conference

Aug 5, 2025, 8:30 AM EDT - 2 months ago

Clene to Present at the Canaccord 45th Annual Growth Conference


Clene to Present at the 37TH Annual Roth Conference

Mar 6, 2025, 8:30 AM EST - 8 months ago

Clene to Present at the 37TH Annual Roth Conference


Clene Announces 1-for-20 Reverse Stock Split

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Clene Announces 1-for-20 Reverse Stock Split


Clene to Present at Upcoming May Conferences

May 14, 2024, 8:00 AM EDT - 1 year ago

Clene to Present at Upcoming May Conferences


Clene to Present at Upcoming September Conferences

Aug 30, 2023, 8:20 AM EDT - 2 years ago

Clene to Present at Upcoming September Conferences


Clene Announces Pricing of $40 Million Public Offering

Jun 16, 2023, 8:00 AM EDT - 2 years ago

Clene Announces Pricing of $40 Million Public Offering


neuroinvestor3
neuroinvestor3 Oct. 25 at 11:46 AM
$CLNN from chatGPT - “I assess the probability of accelerated approval next year for CNM-Au8 in ALS at a moderate but not high level — perhaps in the 30-50% range, contingent on many moving parts.“
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Oct. 25 at 5:48 AM
$CLNN December? I'm ba patient man, but let's talk about November, anyways. Now, then, according to GOOGLE: "By acting as a surrogate endpoint for clinical benefit, NfL data can speed up the drug development process. For rare diseases (like ALS) with limited treatment options, regulatory agencies like the FDA may approve a drug based on strong NfL data alone, with confirmatory trials to follow."
0 · Reply
fibonacci1170
fibonacci1170 Oct. 24 at 8:58 PM
$CLNN 91% reduction in "time to death" after 12 months of therapy. Even the sleazy FDA can't deny accelerated approval, surely. If they do deny, ALS patients should sue the FDA in court and demand an FBI probe. Unfortunately, these government agencies are only good at probing some small-fish casinos that nobody cares about instead of exposing the FDA-pharma mafia that is slaughtering millions of patients by denying them treatment.
0 · Reply
Mulhollandr
Mulhollandr Oct. 24 at 5:32 PM
$CLNN just my opinion but I think someone is grabbigg by shares quietly trying not to spike the price. Wonder when they will be done loading. 🤔
1 · Reply
ransoms2121212
ransoms2121212 Oct. 24 at 3:43 PM
$CLNN volume off to a strong start
1 · Reply
Mulhollandr
Mulhollandr Oct. 23 at 9:47 PM
$CLNN FDA minutes or EAP data…which do we get first? If they are still thinking nda submission could happen this year…data is coming soon? I think shutdown will slow down minutes from type C.
3 · Reply
Scoops1212
Scoops1212 Oct. 23 at 8:12 PM
0 · Reply
Chris150
Chris150 Oct. 23 at 7:31 PM
$CLNN https://www.youtube.com/watch?v=DIo6uZV8sog
0 · Reply
Acx21
Acx21 Oct. 23 at 7:25 PM
$CLNN I was listening to the conference and to make it short: The NfL data is not analysed yet or not available to CLNN by now. Still, Rob seemed to be very confident about a succesful NDA in december if the NfL data is concordant to previous results. The next FDA meeting is scheduled for december and so is the planned timeline for the NDA filling
0 · Reply
LXP
LXP Oct. 23 at 7:24 PM
$CLNN whelp, thoughts? Seems like a little more waiting. Nfl data likely in November. Fda meeting in December. NDA if all goes well, by EOY
0 · Reply
Takeover24
Takeover24 Oct. 23 at 7:23 PM
$CLNN 10 minute update over. Nothing new. Says they dont yet have the NFL data yet which does not make sense based other prior timelines. Did not address whether the FDA meeting on the survival data actually happened end of Q3 or not. That said, still talked about a meeting with the FDA in Dec and the possibility of filing NDA at end of year. Sounded confident. Also talked about cash position being sufficient to get company through these key inflection points (into Q2 of next year).
1 · Reply
LXP
LXP Oct. 23 at 6:42 PM
$CLNN just hoping for some clues where they are at in the process.
0 · Reply
Takeover24
Takeover24 Oct. 23 at 5:11 PM
$CLNN The market is exploding with anticipation about what Rob is going to say at the conference in a few hours 😴
3 · Reply
Mulhollandr
Mulhollandr Oct. 23 at 2:49 PM
$CLNN roughly 70% of the volume today appears to be dark pool. I find this strange considering the volume is so low. 🤔
1 · Reply
neuroinvestor3
neuroinvestor3 Oct. 23 at 2:09 PM
$CLNN https://www.tipranks.com/news/ratings/clenes-cnm-au8-a-promising-game-changer-in-als-treatment-with-buy-rating-from-justin-walsh-ratings
1 · Reply
neuroinvestor3
neuroinvestor3 Oct. 23 at 2:09 PM
$CLNN I don't think we'll get any PR's from Clene related to the FDA until the guv reopens.
1 · Reply
mrpsny
mrpsny Oct. 23 at 12:49 PM
$CLNN wouldn't mind scooping up some more. Issue is, I'll be averaging up. Soo... stay down!!
0 · Reply
Mulhollandr
Mulhollandr Oct. 23 at 11:03 AM
$CLNN c’mon Rob!
0 · Reply
NoFearHere
NoFearHere Oct. 22 at 8:56 PM
$CLNN going back to $6.70 the 50 dma
1 · Reply
Bobfree
Bobfree Oct. 22 at 8:12 PM
$CLNN A no news Wednesday. Shocking. Not that I'm feeling impatient
0 · Reply
neuroinvestor3
neuroinvestor3 Oct. 22 at 5:52 PM
$CLNN down 9% seems extreme on no news.....
1 · Reply
ransoms2121212
ransoms2121212 Oct. 22 at 5:49 PM
$CLNN link for the KOL call on November 4th for anyone else interested—this link comes from the below screenshot. List Justin Walsh as Jones contact @Mulhollandr @Chris150 @neuroinvestor3 @Scoops1212 @fibonacci1170 https://zoom.us/webinar/register/WN_TvHaommTSsuizqBpUauRjg#/registration
1 · Reply